Sign in
Antisense therapy for PTP1B related conditions
Other   Open access

Antisense therapy for PTP1B related conditions

R.N. Veedu and S. Chen
Patent. WRAYS PTY LTD, Vol.WO/2020/077390
Murdoch University
2020
pdf
WO2020077390A1.pdfDownloadView
Open Access

Abstract

An isolated or purified antisense oligomer targeted to a nucleic acid molecule encoding PTPN1 pre-mRNA, wherein the antisense oligomer inhibits the expression of PTP1B.

Details

Metrics

74 File views/ downloads
106 Record Views
Logo image